|
|
|
|
Syros Pharmaceuticals Inc (SYRS) |
|
|
|
| |
SYRS's Net Income Growth by Quarter and Year
Syros Pharmaceuticals Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| SYRS Net Income (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
-4.77
|
-23.81
|
-30.13
|
| III Quarter |
September |
-40.14
|
-30.25
|
-26.03
|
-19.49
|
| II Quarter |
June |
-36.26
|
-34.48
|
-22.49
|
-17.20
|
| I Quarter |
March |
-23.79
|
-25.15
|
-14.23
|
-17.23
|
| FY |
|
-100.19
|
-94.65
|
-86.56
|
-84.05
|
| SYRS Net Income third quarter 2023 Y/Y Growth Comment |
Syros Pharmaceuticals Inc in the third quarter 2023 recorded net loss of $ -40.14 millions.
According to the results reported in the third quarter 2023, Syros Pharmaceuticals Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Syros Pharmaceuticals Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2023.
|
| SYRS Net Income ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
- |
- |
- |
| III Quarter |
September |
- |
- |
- |
- |
| II Quarter |
June |
- |
- |
- |
- |
| I Quarter |
March |
- |
- |
- |
- |
| FY |
|
- |
- |
- |
- |
SYRS Net Income (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
- |
- |
- |
| III Quarter |
September |
- |
- |
- |
- |
| II Quarter |
June |
- |
- |
- |
- |
| I Quarter |
March |
- |
- |
- |
- |
| FY (Year on Year) |
|
- |
- |
- |
- |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
|
| Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Syros Pharmaceuticals Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| SYRS's III. Quarter Q/Q Net Income Comment |
Recent results of -40.14 millions by Syros Pharmaceuticals Inc look even more unfavourable considering the -36.26 millions in the previous quarter.
Within Major Pharmaceutical Preparations industry Syros Pharmaceuticals Inc achieved highest sequential Net Income growth. While Syros Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is . |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 0 % |
0 % |
0 % |
|
|
|
| SYRS's III. Quarter Q/Q Net Income Comment |
III. Quarter 2023 net loss of -40.14 millions by Syros Pharmaceuticals Inc come out even less good compare to the -36.26 millions net loss in the previous quarter.
Within Major Pharmaceutical Preparations industry Syros Pharmaceuticals Inc achieved highest sequential Net Income growth. While Syros Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is . |
|
Syros Pharmaceuticals Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
| Cumulative Net Income 12 Months Ending |
$ -104.96 |
$ -95.07 |
$ -93.30 |
$ -94.65 |
$ -113.69 |
| Y / Y Net Income Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year Net Income Growth Overall
Ranking |
# |
# |
# |
# |
# |
| Seqeuential Net Income Change (TTM) |
- |
- |
- |
- |
- |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# |
# |
# |
# |
# |
| Cumulative Net Income growth
Comment |
Syros Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. . |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# |
| Sector |
# |
| S&P 500 |
# |
|
| Cumulative Net Income growth
Comment |
Syros Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. . |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# |
| Sector |
# |
| S&P 500 |
# |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
55.53%